140 related articles for article (PubMed ID: 38365182)
1. Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
Caon E; Martins M; Hodgetts H; Blanken L; Vilia MG; Levi A; Thanapirom K; Al-Akkad W; Abu-Hanna J; Baselli G; Hall AR; Luong TV; Taanman JW; Vacca M; Valenti L; Romeo S; Mazza G; Pinzani M; Rombouts K
J Hepatol; 2024 Jun; 80(6):941-956. PubMed ID: 38365182
[TBL] [Abstract][Full Text] [Related]
2. The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.
Bruschi FV; Claudel T; Tardelli M; Caligiuri A; Stulnig TM; Marra F; Trauner M
Hepatology; 2017 Jun; 65(6):1875-1890. PubMed ID: 28073161
[TBL] [Abstract][Full Text] [Related]
3. PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells.
Bruschi FV; Tardelli M; Einwallner E; Claudel T; Trauner M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218077
[TBL] [Abstract][Full Text] [Related]
4. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
[TBL] [Abstract][Full Text] [Related]
5.
Bruschi FV; Claudel T; Tardelli M; Starlinger P; Marra F; Trauner M
Hepatol Commun; 2019 Sep; 3(9):1191-1204. PubMed ID: 31497741
[TBL] [Abstract][Full Text] [Related]
6. MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis.
Pydyn N; Ferenc A; Trzos K; Pospiech E; Wilamowski M; Mucha O; Major P; Kadluczka J; Rodrigues PM; Banales JM; Herranz JM; Avila MA; Hutsch T; Malczak P; Radkowiak D; Budzynski A; Jura J; Kotlinowski J
Cell Mol Gastroenterol Hepatol; 2024; 17(6):887-906. PubMed ID: 38311169
[TBL] [Abstract][Full Text] [Related]
7. Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.
Jönsson C; Bergram M; Kechagias S; Nasr P; Ekstedt M
Scand J Gastroenterol; 2024 Jun; 59(6):737-741. PubMed ID: 38563432
[TBL] [Abstract][Full Text] [Related]
8. PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells.
Rady B; Nishio T; Dhar D; Liu X; Erion M; Kisseleva T; Brenner DA; Pocai A
PLoS One; 2021; 16(12):e0260721. PubMed ID: 34879108
[TBL] [Abstract][Full Text] [Related]
9. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein.
Johnson SM; Bao H; McMahon CE; Chen Y; Burr SD; Anderson AM; Madeyski-Bengtson K; Lindén D; Han X; Liu J
Nat Commun; 2024 Jun; 15(1):4847. PubMed ID: 38844467
[TBL] [Abstract][Full Text] [Related]
10. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
11. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression.
Volkert I; Fromme M; Schneider C; Candels L; Lindhauer C; Su H; Thorhauge K; Pons M; Mohamed MR; Schneider KM; Strnad P; Trautwein C
Hepatology; 2024 Apr; 79(4):898-911. PubMed ID: 37625151
[TBL] [Abstract][Full Text] [Related]
12. IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease.
Park J; Zhao Y; Zhang F; Zhang S; Kwong AC; Zhang Y; Hoffmann HH; Bushweller L; Wu X; Ashbrook AW; Stefanovic B; Chen S; Branch AD; Mason CE; Jung JU; Rice CM; Wu X
J Hepatol; 2023 Jan; 78(1):45-56. PubMed ID: 36049612
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.
Banini BA; Kumar DP; Cazanave S; Seneshaw M; Mirshahi F; Santhekadur PK; Wang L; Guan HP; Oseini AM; Alonso C; Bedossa P; Koduru SV; Min HK; Sanyal AJ
Hepatology; 2021 Apr; 73(4):1290-1306. PubMed ID: 33131062
[TBL] [Abstract][Full Text] [Related]
14. The health care experience of adults with metabolic dysfunction-associated steatohepatitis and influence of PNPLA3: A qualitative study.
Stine JG; Medic N; Pettersson B; Venerus M; Blau JE
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780312
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis.
Pingitore P; Dongiovanni P; Motta BM; Meroni M; Lepore SM; Mancina RM; Pelusi S; Russo C; Caddeo A; Rossi G; Montalcini T; Pujia A; Wiklund O; Valenti L; Romeo S
Hum Mol Genet; 2016 Dec; 25(23):5212-5222. PubMed ID: 27742777
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptome Analysis Identified Core Genes and Transcription Factors in Mesenchymal Cell Differentiation during Liver Cirrhosis.
Dai X; Zheng HL; Ma YX; Wang YY; Wang MQ; Cai HY; Hu ZH; Wan J; Zhang L
Front Biosci (Landmark Ed); 2024 Feb; 29(2):62. PubMed ID: 38420807
[TBL] [Abstract][Full Text] [Related]
17. Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH.
Bruschi FV; Tardelli M; Herac M; Claudel T; Trauner M
Liver Int; 2020 May; 40(5):1098-1110. PubMed ID: 32043752
[TBL] [Abstract][Full Text] [Related]
18. PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction.
Gou Y; Wang L; Zhao J; Xu X; Xu H; Xie F; Wang Y; Feng Y; Zhang J; Zhang Y
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298640
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.
Pirazzi C; Valenti L; Motta BM; Pingitore P; Hedfalk K; Mancina RM; Burza MA; Indiveri C; Ferro Y; Montalcini T; Maglio C; Dongiovanni P; Fargion S; Rametta R; Pujia A; Andersson L; Ghosal S; Levin M; Wiklund O; Iacovino M; Borén J; Romeo S
Hum Mol Genet; 2014 Aug; 23(15):4077-85. PubMed ID: 24670599
[TBL] [Abstract][Full Text] [Related]
20. AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M.
Tardelli M; Bruschi FV; Claudel T; Moreno-Viedma V; Halilbasic E; Marra F; Herac M; Stulnig TM; Trauner M
Sci Rep; 2017 Nov; 7(1):14661. PubMed ID: 29116096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
